First Time Loading...

2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 4.63 USD -0.43% Market Closed
Updated: Apr 24, 2024

Intrinsic Value

2seventy Bio, Inc. operates as cell and gene therapy company. [ Read More ]

The intrinsic value of one TSVT stock under the Base Case scenario is 3.25 USD. Compared to the current market price of 4.63 USD, 2Seventy Bio Inc is Overvalued by 30%.

Key Points:
TSVT Intrinsic Value
Base Case
3.25 USD
Overvaluation 30%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
2Seventy Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TSVT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
2Seventy Bio Inc

Provide an overview of the primary business activities
of 2Seventy Bio Inc.

What unique competitive advantages
does 2Seventy Bio Inc hold over its rivals?

What risks and challenges
does 2Seventy Bio Inc face in the near future?

Has there been any significant insider trading activity
in 2Seventy Bio Inc recently?

Summarize the latest earnings call
of 2Seventy Bio Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for 2Seventy Bio Inc.

Provide P/S
for 2Seventy Bio Inc.

Provide P/E
for 2Seventy Bio Inc.

Provide P/OCF
for 2Seventy Bio Inc.

Provide P/FCFE
for 2Seventy Bio Inc.

Provide P/B
for 2Seventy Bio Inc.

Provide EV/S
for 2Seventy Bio Inc.

Provide EV/GP
for 2Seventy Bio Inc.

Provide EV/EBITDA
for 2Seventy Bio Inc.

Provide EV/EBIT
for 2Seventy Bio Inc.

Provide EV/OCF
for 2Seventy Bio Inc.

Provide EV/FCFF
for 2Seventy Bio Inc.

Provide EV/IC
for 2Seventy Bio Inc.

Show me price targets
for 2Seventy Bio Inc made by professional analysts.

What are the Revenue projections
for 2Seventy Bio Inc?

How accurate were the past Revenue estimates
for 2Seventy Bio Inc?

What are the Net Income projections
for 2Seventy Bio Inc?

How accurate were the past Net Income estimates
for 2Seventy Bio Inc?

What are the EPS projections
for 2Seventy Bio Inc?

How accurate were the past EPS estimates
for 2Seventy Bio Inc?

What are the EBIT projections
for 2Seventy Bio Inc?

How accurate were the past EBIT estimates
for 2Seventy Bio Inc?

Compare the revenue forecasts
for 2Seventy Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of 2Seventy Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of 2Seventy Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of 2Seventy Bio Inc compared to its peers.

Compare the P/E ratios
of 2Seventy Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing 2Seventy Bio Inc with its peers.

Analyze the financial leverage
of 2Seventy Bio Inc compared to its main competitors.

Show all profitability ratios
for 2Seventy Bio Inc.

Provide ROE
for 2Seventy Bio Inc.

Provide ROA
for 2Seventy Bio Inc.

Provide ROIC
for 2Seventy Bio Inc.

Provide ROCE
for 2Seventy Bio Inc.

Provide Gross Margin
for 2Seventy Bio Inc.

Provide Operating Margin
for 2Seventy Bio Inc.

Provide Net Margin
for 2Seventy Bio Inc.

Provide FCF Margin
for 2Seventy Bio Inc.

Show all solvency ratios
for 2Seventy Bio Inc.

Provide D/E Ratio
for 2Seventy Bio Inc.

Provide D/A Ratio
for 2Seventy Bio Inc.

Provide Interest Coverage Ratio
for 2Seventy Bio Inc.

Provide Altman Z-Score Ratio
for 2Seventy Bio Inc.

Provide Quick Ratio
for 2Seventy Bio Inc.

Provide Current Ratio
for 2Seventy Bio Inc.

Provide Cash Ratio
for 2Seventy Bio Inc.

What is the historical Revenue growth
over the last 5 years for 2Seventy Bio Inc?

What is the historical Net Income growth
over the last 5 years for 2Seventy Bio Inc?

What is the current Free Cash Flow
of 2Seventy Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for 2Seventy Bio Inc.

Financials

Balance Sheet Decomposition
2Seventy Bio Inc

Current Assets 237.8m
Cash & Short-Term Investments 217m
Receivables 13.4m
Other Current Assets 7.4m
Non-Current Assets 327.7m
Long-Term Investments 4.8m
PP&E 278.1m
Intangibles 6.6m
Other Non-Current Assets 38.1m
Current Liabilities 59.8m
Accounts Payable 6m
Accrued Liabilities 38.3m
Other Current Liabilities 15.4m
Non-Current Liabilities 250.3m
Other Non-Current Liabilities 250.3m
Efficiency

Earnings Waterfall
2Seventy Bio Inc

Revenue
100.4m USD
Cost of Revenue
-16.9m USD
Gross Profit
83.5m USD
Operating Expenses
-300.4m USD
Operating Income
-216.9m USD
Other Expenses
-632k USD
Net Income
-217.6m USD

Free Cash Flow Analysis
2Seventy Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

TSVT Profitability Score
Profitability Due Diligence

2Seventy Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive Revenue Growth Forecast
Negative Operating Income
24/100
Profitability
Score

2Seventy Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

TSVT Solvency Score
Solvency Due Diligence

2Seventy Bio Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

2Seventy Bio Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TSVT Price Targets Summary
2Seventy Bio Inc

Wall Street analysts forecast TSVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSVT is 11.22 USD with a low forecast of 5.05 USD and a high forecast of 26.25 USD.

Lowest
Price Target
5.05 USD
9% Upside
Average
Price Target
11.22 USD
142% Upside
Highest
Price Target
26.25 USD
467% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

TSVT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

TSVT Price
2Seventy Bio Inc

1M 1M
-6%
6M 6M
+24%
1Y 1Y
-45%
3Y 3Y
-66%
5Y 5Y
-66%
10Y 10Y
-66%
Annual Price Range
4.63
52w Low
1.57
52w High
12.48
Price Metrics
Average Annual Return 14.41%
Standard Deviation of Annual Returns 112.63%
Max Drawdown -96%
Shares Statistics
Market Capitalization 234.4m USD
Shares Outstanding 51 311 100
Percentage of Shares Shorted 13.42%

TSVT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

2Seventy Bio Inc Logo
2Seventy Bio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

234.4m USD

Dividend Yield

0%

Description

2seventy Bio, Inc. operates as cell and gene therapy company. The company is headquartered in Cambridge, Massachusetts and currently employs 437 full-time employees. The company went IPO on 2021-10-18. The firm is focused on the research, development, and commercialization of transformative treatments for cancer. Its approach combines its expertise in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. The company is advancing multiple preclinical and clinical programs in oncology. The firm's lead preclinical programs in B cell non-Hodgkin's lymphoma (B-NHL) and acute myeloid leukemia are illustrations of its multiplex approach applied to address the specific challenges of treating those cancers. The company is developing bbT369 product candidate as a treatment for patients with B-NHL.

Contact

MASSACHUSETTS
Cambridge
60 Binney Street
+13394999300.0

IPO

2021-10-18

Employees

437

Officers

President & Director
Mr. Nick Leschly
Chief Scientific Officer
Dr. Philip D. Gregory D. Phil., DPHIL
Chief Executive Officer
Mr. William D. Baird III, M.B.A.
Chief Financial Officer
Vicki Eatwell
Senior VP of Quality and Head of Operations
Jessica Snow
Chief Technology Officer
Ms. Susan Abu-Absi Ph.D.
Show More
Senior VP, General Counsel & Corporate Secretary
Ms. Teresa L. Jurgensen J.D.
Head of People & Culture
Ms. Kerri Jensen
Senior Vice President of Corporate Affairs
Ms. Jenn Snyder
Chief Medical Officer
Dr. Steven Bernstein M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one TSVT stock?

The intrinsic value of one TSVT stock under the Base Case scenario is 3.25 USD.

Is TSVT stock undervalued or overvalued?

Compared to the current market price of 4.63 USD, 2Seventy Bio Inc is Overvalued by 30%.